Beta Bionics
- Country
- Ownership
- -
- Employees
- 294
- Market Cap
- -
- Introduction
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Medtronic Submits Interoperable Insulin Pump to FDA, Advancing Abbott Partnership
Medtronic has submitted 510(k) applications to the FDA for its MiniMed 780G pump as an alternate controller enabled device and its SmartGuard algorithm as an interoperable automated glycemic controller.
iLet Bionic Pancreas Shows Equal Efficacy in Primary Care and Specialty Settings for Type 1 Diabetes
The iLet Bionic Pancreas automated insulin delivery system achieved target glucose levels in 97% of adults with type 1 diabetes, with no significant differences between primary care and endocrinology settings.
Beta Bionics iLet Bionic Pancreas Integrates with Abbott FreeStyle Libre 3 Plus CGM
Beta Bionics has launched the integration of its iLet bionic pancreas with Abbott's FreeStyle Libre 3 Plus CGM, streamlining diabetes management.